Corticosteroids for sore throat: a clinical practice guideline
Author
dc.contributor.author
Aertgeerts, Bert
Author
dc.contributor.author
Agoritsas, Thomas
Author
dc.contributor.author
Siemieniuk, Reed A. C.
Author
dc.contributor.author
Brignardello Petersen, Romina
Admission date
dc.date.accessioned
2018-06-29T15:15:36Z
Available date
dc.date.available
2018-06-29T15:15:36Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
BMJ 2017;358: j4090
es_ES
Identifier
dc.identifier.other
10.1136/bmj.j4090
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/149358
Abstract
dc.description.abstract
What is the role of a single dose of oral corticosteroids for those with acute sore throat? Using the GRADE framework according to the BMJ Rapid Recommendation process, an expert panel make a weak recommendation in favour of corticosteroid use. The panel produced these recommendations based on a linked systematic review triggered by a large randomised trial published in April 2017. This trial reported that corticosteroids increased the proportion of patients with complete resolution of pain at 48 hours. Box 1 shows all of the articles and evidence linked in this Rapid Recommendation package. The infographic provides the recommendation together with an overview of the absolute benefits and harms of corticosteroids in the standard GRADE format. Table 2 below shows any evidence that has emerged since the publication of this article. Clinicians and their patients can find consultation decision aids to facilitate shared decision making in MAGICapp (www.magicapp.org/goto/guideline/JjXYAL/section/j79pvn).